Capital Advisors Wealth Management, LLC Esperion Therapeutics, Inc. Transaction History
Capital Advisors Wealth Management, LLC
- $681 Million
- Q3 2025
A detailed history of Capital Advisors Wealth Management, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Capital Advisors Wealth Management, LLC holds 42,555 shares of ESPR stock, worth $120,856. This represents 0.02% of its overall portfolio holdings.
Number of Shares
42,555
Previous 42,555
-0.0%
Holding current value
$120,856
Previous $41,000
173.17%
% of portfolio
0.02%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding ESPR
# of Institutions
184Shares Held
106MCall Options Held
139KPut Options Held
604K-
Black Rock Inc. New York, NY14MShares$39.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$33.3 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT10.3MShares$29.4 Million0.05% of portfolio
-
Two Seas Capital LP Rye, NY9.95MShares$28.3 Million0.18% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16.68MShares$19 Million4.26% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $189M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...